The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Giraudo Bryan since 2018.
This trader's CIK number is 1740847.
At the time of last reporting, Giraudo Bryan was the COO/CFO of Gossamer Bio, Inc.. (stock ticker symbol GOSS).
Also see all insider trading activities at Gossamer Bio, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | GOSS | 100,000 | $59,100 | 6,430 | $7,433 | 0 | $0 |
2023 | GOSS | 105,000 | $104,550 | 0 | $0 | 0 | $0 |
2022 | GOSS | 13,869 | $99,995 | 10,722 | $95,586 | 0 | $0 |
2020 | GOSS | 5,000 | $55,958 | 0 | $0 | 0 | $0 |
2019 | GOSS | 8,121 | $133,510 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2019 | PTGX | 8,000 | $45,624 | 0 | $0 | 0 | $0 |
2017 | PTGX | 10,000 | $64,570 | 0 | $0 | 0 | $0 |
2. Protagonist Therapeutics, Inc (PTGX)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-06-18 | GOSS | Buy | 100,000 | .59 | 59,100 |
2024-03-27 | GOSS | Sale | 6,430 | 1.16 | 7,433 |
2023-04-04 | GOSS | Buy | 55,000 | 1.02 | 56,100 |
2023-03-20 | GOSS | Buy | 50,000 | .97 | 48,450 |
2022-07-15 | GOSS | Buy | 13,869 | 7.21 | 99,995 |
2022-03-23 | GOSS | Sale | 10,722 | 8.91 | 95,586 |
2020-10-14 | GOSS | Buy | 3,000 | 10.01 | 30,036 |
2020-06-23 | GOSS | Buy | 2,000 | 12.96 | 25,922 |
2019-09-26 | GOSS | Buy | 1,121 | 16.78 | 18,810 |
2019-05-30 | GOSS | Buy | 1,000 | 18.70 | 18,700 |
2019-02-12 | GOSS | Buy | 6,000 | 16.00 | 96,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-12-03 | PTGX | Buy | 8,000 | 5.70 | 45,624 |
2017-05-16 | PTGX | Buy | 10,000 | 6.46 | 64,570 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Giraudo Bryan (COO/CFO of Gossamer Bio, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.